Open AccessCould Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
Author(s) -
Hessamoddin Roustaei,
Zahra Kiamanesh,
Emran Askari,
Ramin Sadeghi,
Kamran Aryana,
Giorgio Treglia
Publication year - 2022
Publication title -
contrast media and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.714
H-Index - 50
eISSN - 1555-4317
pISSN - 1555-4309
DOI - 10.1155/2022/3948873
Subject(s) - fibroblast activation protein, alpha , medicine , context (archaeology) , avidity , meta analysis , cancer , odds ratio , clinical trial , nuclear medicine , oncology , immunology , antibody , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom